Leuprolide
A powerful GnRH agonist that helps manage hormone-sensitive conditions by controlling hormone production.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Suggested dose
1 mg
Compound profile
Scientific & efficacy data
Hormone Support
Peptide profile
Strong human trials
Leuprolide
1 mg · Once daily
Molecular formula
C59H84N16O12
- Mol. weight
- 1209.4 g/mol
- CAS number
- 74381-53-6
- PubChem
- 657181
- Developed · 1985
- TAP Pharmaceuticals Research Team
TAP Pharmaceuticals (Abbott Laboratories & Takeda joint venture)
Amino acid sequence
pyroGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEtDosing
How much do I take?
1 mg · once daily · subcutaneous
1 mg
Once daily
Covers all 4 documented dose levels · 2 administration routes · timing · dose-adjustment guidance.
Suitability
Is this right for me?
Best for managing advanced or metastatic prostate cancer & controlling severe endometriosis pain
Best for
Managing advanced or metastatic prostate cancer
Leuprolide is particularly well-suited for individuals focused on managing advanced or metastatic prostate cancer. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1][5].
Controlling severe endometriosis pain
Leuprolide is particularly well-suited for individuals focused on controlling severe endometriosis pain. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1].
Treating symptomatic uterine fibroids
Leuprolide is particularly well-suited for individuals focused on treating symptomatic uterine fibroids. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1].
Delaying early puberty in children
Leuprolide is particularly well-suited for individuals focused on delaying early puberty in children. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach [1].
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Leuprolide with similar peptides to find the best fit for your goals.
Administration
How do I use it?
Subcutaneous injection (daily) · Intramuscular injection (monthly depot)
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is it safe?
15 common side effects · 1 serious
Leuprolide (Lupron) is an FDA-approved GnRH agonist with 35+ years of clinical safety data involving millions of patients in oncology and endocrinology.
[1] The critical safety issue is the initial 5-7 day flare effect—temporary surge in FSH/LH causing symptom worsening before hormone suppression begins—particularly dangerous for prostate cancer patients (flare can cause urinary obstruction or spinal cord compression).
[5] Bone density loss is a dose-dependent long-term risk in both men and women requiring monitoring. [1][5] Injection site reactions, hot flushes, and initial hypogonadal symptoms are expected and typically transient. [5]
Leuprolide safety is well-established through FDA registration trials, extensive post-marketing surveillance, and hundreds of published clinical studies spanning endometriosis, prostate cancer, precocious puberty, and breast cancer indications.
Long-term safety data from 10+ years of continuous therapy shows predictable hypogonadal effects with manageable metabolic consequences when monitored appropriately. [1][3] Black box warnings exist for flare risk in certain prostate cancer scenarios and bone loss risk in extended use.
Common side effects · experienced by some users
Hot flashes (very common in men)
Hot flashes (very common in men)
Management: Consult your healthcare provider for guidance.
Decreased libido and erectile dysfunction
Decreased libido and erectile dysfunction
Management: Consult your healthcare provider for guidance.
Injection site pain or swelling
Injection site pain or swelling
Management: Consult your healthcare provider for guidance.
Nausea
Nausea
Management: Consult your healthcare provider for guidance.
Fatigue
Fatigue
Management: Consult your healthcare provider for guidance.
Mood changes or depression
Mood changes or depression
Management: Consult your healthcare provider for guidance.
Joint or muscle pain
Joint or muscle pain
Management: Consult your healthcare provider for guidance.
Headaches
Headaches
Management: Consult your healthcare provider for guidance.
Dizziness
Dizziness
Management: Consult your healthcare provider for guidance.
Thinning hair
Thinning hair
Management: Consult your healthcare provider for guidance.
Decreased bone density (osteoporosis with long-term use)
Decreased bone density (osteoporosis with long-term use)
Management: Consult your healthcare provider for guidance.
QT prolongation (rare but serious cardiac effect)
QT prolongation (rare but serious cardiac effect)
Management: Consult your healthcare provider for guidance.
Tumor flare (temporary worsening of cancer symptoms in first weeks)
Tumor flare (temporary worsening of cancer symptoms in first weeks) [1][5]
Management: Consult your healthcare provider for guidance.
Severe allergic reactions
Severe allergic reactions
Management: Consult your healthcare provider for guidance.
Spinal cord compression risk in men with metastatic disease
Spinal cord compression risk in men with metastatic disease
Management: Consult your healthcare provider for guidance.
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Leuprolide
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Leuprolide should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- Safe:Anti-androgens (like bicalutamide) for prostate cancer — May be used together under medical guidance.
- Safe:NSAIDs (like naproxen) for endometriosis pain — May be used together under medical guidance.
- Safe:Bone-protecting agents (bisphosphonates) for long-term use — May be used together under medical guidance.
With medications
- Caution:Other GnRH agonists (would cause overdosing) — Use with caution—discuss with your healthcare provider.
- Caution:Certain medications that prolong QT interval — Use with caution—discuss with your healthcare provider.
- Caution:Avoid if taking medications that significantly interact with testosterone suppression — Use with caution—discuss with your healthcare provider.
With supplements
- Safe:Multivitamins — Generally safe to take alongside Leuprolide. Space doses apart if taking oral formulations to ensure optimal absorption.
- Safe:Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
How do I know it's working?
Strong human trials · first signs initial_response
Evidence level
Strong human trials
(Phase 3 or FDA approved)
Regulatory status
FDA approved for this use
Onset of effects
Moderate
(1-2 weeks)
How it works
Leuprolide works by pretending to be your brain's natural GnRH hormone, but in a way that confuses your pituitary gland.
For the first week, it actually stimulates hormone production, but then your body gets exhausted and shuts down the whole system. This stops testosterone in men and estrogen in women—exactly what you need for hormone-sensitive conditions like prostate cancer and endometriosis.
Think of it as a switch that flips on briefly, then locks in the off position [1].
The deeper mechanism
Leuprolide is a synthetic nonapeptide (9-amino acid sequence: pyroGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt) that acts as a potent GnRH receptor agonist. [1][4] Upon subcutaneous or intramuscular administration, leuprolide binds to GnRH receptors in the anterior pituitary with high affinity.
Initial agonistic activity causes rapid release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which increases testosterone production initially—this is termed 'flare.'
However, continuous exposure to leuprolide causes receptor desensitization and downregulation within 7-14 days, resulting in profound suppression of gonadotropin secretion.
This eliminates the LH stimulus for Leydig cell testosterone production (in males) or the FSH/LH stimulus for ovarian estrogen production (in females). Testosterone and estrogen levels typically drop 90-95% within 2-4 weeks.
The sustained suppression continues as long as the medication is administered. Leuprolide's half-life is 2-3 hours for daily formulations, but depot formulations with fatty acid conjugation have extended half-lives of 2-5 weeks, enabling monthly to quarterly dosing through slow-release mechanisms.
What to expect
initial_response
What you might notice
- May experience tumor flare (temporary worsening) if used for cancer;
- hot flashes and decreased libido begin
What's normal
- Full integration of Leuprolide into physiological systems is established
- Long-term Leuprolide response remains personalized to your physiology
- Leuprolide tolerance is well-maintained with consistent dosing
What's next
- Maintain your established Leuprolide protocol for sustained benefits
- Continue periodic monitoring to confirm Leuprolide efficacy
- Review comprehensive Leuprolide response with your provider
peak_effect
What you might notice
- Full testosterone suppression achieved;
- endometriosis pain relief becomes noticeable;
- tumor flare typically resolves
What's normal
- Leuprolide has achieved stable, long-term homeostatic integration
- Sustained efficacy of Leuprolide remains consistent
- Chronic Leuprolide effects remain stable and predictable
What's next
- Maintain your established Leuprolide protocol for sustained benefits
- Continue periodic monitoring to confirm Leuprolide efficacy
- Review comprehensive Leuprolide response with your provider
long_term
What you might notice
- Sustained hormone suppression;
- continued symptom relief;
- bone density monitoring becomes important;
- most side effects stabilize
What's normal
- Full therapeutic effects of Leuprolide are well-characterized at this point
- Maintenance of Leuprolide's therapeutic effects is typical
- Tolerance patterns with Leuprolide are generally stable over months
What's next
- Comprehensive assessment of Leuprolide efficacy should be conducted
- Discuss long-term continuation, cycling, or protocol modifications
- Continue regular monitoring of relevant biomarkers or symptoms
Signs it's working
Treatment Response
- Improvement in the primary symptoms or condition being treated
- Positive changes in relevant lab values or clinical markers
- Consistent, stable response to Leuprolide over time
- Reduction in symptom frequency or severity
General Well-being
- Improved energy levels and daily functioning
- Better quality of life related to the treated condition
- Manageable or absent side effects indicating good tolerance
- Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- Insufficient time at target dose—most compounds need several weeks to show full benefits
- Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- Individual variation in response—genetics, metabolism, and other factors affect outcomes
- Underlying conditions or medications interfering with absorption or effectiveness
- Improper storage leading to degraded product—always verify proper storage conditions
Key research
Clinical trials
Tested in people
464 registered studies, 58 still enrolling.
By phase
A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.
What kind of research
About 87,747 people took part in the studies that actually administered Leuprolide. Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.
Most recent
QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy
Hebei Medical University Fourth Hospital
Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs.
UNICANCER
BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder
University of Illinois at Chicago
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when Leuprolide is named as an intervention; studies that only mention it in passing are not.
Questions
Frequently asked
Is leuprolide a steroid?
Can I get pregnant while taking leuprolide?
How long do I need to take leuprolide?
That depends on your condition. For prostate cancer, it's usually long-term or continuous. For endometriosis or fibroids, treatment typically lasts 3-12 months. Your doctor will determine the right duration for you [1].
What's the difference between daily and depot leuprolide?
Further reading
History & related research
History · since 1985
The first GnRH drug that gave hope to cancer patients in 1985
Leuprolide is a man-made hormone that stops the body from making certain sex hormones. Doctors use it to treat prostate cancer, endometriosis, uterine fibroids, early puberty, and to help with fertility treatments.
Read the full history of LeuprolideReady for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Leuprolide, on one page.